Evidence map›Paper›PMID 39342272›Full record

ArticleBMC psychology2024

Study Protocol for a Cluster, Randomized, Controlled Community Effectiveness Trial of the Early Start Denver Model (ESDM) Compared to Community Early Behavioral Intervention (EBI) in Community Programs serving Young Autistic Children: Partnering for Autism: Learning more to improve Services (PALMS).

Aubyn C Stahmer, Sarah Dufek, Sally J Rogers, Ana-Maria Iosif

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMC psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06005285 (Examining the Effectiveness of the Early Start Denver Model in Community Programs), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06005285 narecruitingnot on this map

Examining the Effectiveness of the Early Start Denver Model in Community Programs

TypeinterventionalSponsorUniversity of California, DavisRan2024 to 2028Enrolled600ConditionsAutismArmsEarly Start Denver Model (ESDM), Early Intensive Behavioral Intervention (EIBI)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aubyn C StahmerUC Davis Health, MIND Institute, University of California, 2825 50th St., Sacramento, CA, 95819, USA. astahmer@ucdavis.edu.
Sarah DufekUC Davis Health, MIND Institute, University of California, 2825 50th St., Sacramento, CA, 95819, USA.
Sally J RogersUC Davis Health, MIND Institute, University of California, 2825 50th St., Sacramento, CA, 95819, USA.
Ana-Maria IosifUC Davis Health, Department of Public Health Sciences, University of California, One Shields Ave., Davis, CA, 95616, USA.

Funding

Research Project: Pathologic Significance of Maternal AutoantibodiesP50HD103526 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEONARD J. ABBEDUTO, Melissa Dawn Bauman · 2020 to 2026
$9.7M
Examining the Effectiveness of the Early Start Denver Model in Community Programs serving Young Autistic ChildrenR01MH131703 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Aubyn C. Stahmer · 2023 to 2026
$3.8M
NICHD NIH HHS P50 HD103526NIMH NIH HHS R01 MH131703
6 · The paper itself

Abstract

backgroundThe rising number of children identified with autism has led to exponential growth in for-profit applied behavior analysis (ABA) agencies and the use of highly structured approaches that may not be developmentally appropriate for young children. Multiple clinical trials support naturalistic developmental behavior interventions (NDBIs) that integrate ABA and developmental science and are considered best practices for young autistic children. The Early Start Denver Model (ESDM) is a comprehensive NDBI shown to improve social communication outcomes for young autistic children in several controlled efficacy studies. However, effectiveness data regarding NDBI use in community-based agencies are limited.

methodsThis study uses a community-partnered approach to test the effectiveness of ESDM compared to usual early behavioral intervention (EBI) for improving social communication and language in autistic children served by community agencies. This is a hybrid type 1 cluster-randomized controlled trial with 2 conditions: ESDM and EBI. In the intervention group, supervising providers will receive training in ESDM; in the control group, they will continue EBI as usual. We will enroll and randomize 100 supervisors (50 ESDM, 50 EBI) by region. Each supervisor enrolls 3 families of autistic children under age 5 (n = 300) and accompanying behavior technicians (n = 200). The primary outcome is child language and social communication at 6 and 12 months. Secondary outcomes include child adaptive behavior, caregiver use of ESDM strategies, and provider intervention fidelity. Child social motivation and caregiver fidelity will be tested as mediating variables. ESDM implementation determinants will be explored using mixed methods. DISCUSSION: This study will contribute novel knowledge on ESDM effectiveness, the variables that mediate and moderate child outcomes, and engagement of its mechanisms in community use. We expect results from this trial to increase community availability of this model and access to high-quality intervention for young autistic children, especially those who depend on publicly funded intervention services. Understanding implementation determinants will aid scale-up of effective models within communities. TRAIL REGISTRATION: Clinicaltrials.gov identifier number NCT06005285. Registered on August 21, 2023. PROTOCOL VERSION: Issue date 6 August 2024; Protocol amendment number: 02.

Indexed as

Autistic DisorderBehavior TherapyChild, PreschoolEarly Intervention, EducationalFemaleHumansInfantMaleRandomized Controlled Trials as TopicAutismCommunity implementationEarly interventionEarly start Denver modelNDBI

Identifiers

PMID39342272
PMCPMC11438037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.